A Parasite Coat Protein Binds Suramin to Confer Drug Resistance
Zeelen, J.; van Straaten, M.; Verdi, J.; Hempelmann, A.; Hashemi, H.; Perez, K.; Jeffrey, P. D.; Haelg, S.; Wiedemar, N.; Maeser, P.; Papavasiliou, F. N.; Stebbins, C. E.
Show abstract
Suramin has been a primary early-stage treatment for African trypanosomiasis for nearly one hundred years. Recent studies revealed that trypanosome strains that express the Variant Surface Glycoprotein VSGsur possess heightened resistance to suramin. We show here that VSGsur binds tightly to suramin, other VSGs do not, and that together with VSG13 it defines a structurally divergent subgroup of these coat proteins. The co-crystal structure of VSGsur with suramin reveals that the chemically symmetric drug binds within a large cavity in the VSG homodimer asymmetrically, primarily through contacts of its central benzene rings. Structure-based, loss-of-contact mutations in VSGsur significantly decrease the affinity to suramin and lead to a loss of the resistance phenotype. Altogether, these data show that the resistance phenotype is dependent on the binding of suramin to VSGsur, establishing that the VSG proteins can possess functionality beyond their role in antigenic variation.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Conformational plasticity across phylogenetic clusters of RND multidrug efflux pumps and its impact on substrate specificity 96%
- Cryo-EM Structures of HIV-1 trimer bound to CD4-mimetics M48U1 and BNM-III-170 adopt a CD4-bound open conformation 96%
- Structural basis for triacylglyceride extraction frommycobacterial inner membrane by MFS transporter Rv1410 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.